$47.5 1.7 3.8%
Last Trade - 09/04/21
| Market Cap | £3.02bn |
| Enterprise Value | £2.94bn |
| Revenue | £251.6m |
| Position in Universe | 1569th / 6827 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 0.000 | 48.6 | 105.4 | 229.7 | 344.9 | 535.3 | 770.5 | +92.2% | ||
| -36.9 | +52.7 | |||||||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Progyny, Inc. is a fertility benefits management company specializing in fertility and family building benefits solutions in the United States. The Company operates in one segment that is providing fertility and pharmacy benefits solutions. The Company also offers a benefits plan for the doctors and members. In addition to its fertility benefits solution, it offers an integrated pharmacy benefits solution, Progyny Rx. Progyny Rx provides its members with access to the medications needed during their fertility treatments.
| Last Annual | December 31st, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | April 3, 2008 |
| Public Since | October 25, 2019 |
| No. of Shareholders: | 67 |
| No. of Employees: | 210 |
| Sector | Healthcare |
| Industry | Healthcare Providers & Services |
| Index | Nasdaq Composite , |
| Exchange | NASDAQ Global Select Market |
| Shares in Issue | 87,215,936 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | 1359 BROADWAY 2ND FLOOR, NEW YORK, 10018, United States |
| Web | https://www.progyny.com/ |
| Phone | +1 212 8883124 |
| Contact | () |
| Auditors | Ernst & Young LLP |
As of 09/04/21, shares in Progyny Inc are trading at $47.5, giving the company a market capitalisation of £3.02bn. This share price information is delayed by 15 minutes.
Shares in Progyny Inc are currently trading at $47.5 and the price has moved by 0.124k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Progyny Inc price has moved by 50.81% over the past year.
There are no analysts currently covering Progyny Inc.
Progyny Inc is scheduled to issue upcoming financial results on the following dates:
Progyny Inc does not currently pay a dividend.
Progyny Inc does not currently pay a dividend.
Progyny Inc does not currently pay a dividend.
To buy shares in Progyny Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Progyny Inc are currently trading at $47.5, giving the company a market capitalisation of £3.02bn.
Here are the trading details for Progyny Inc:
Based on an overall assessment of its quality, value and momentum, Progyny Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Progyny Inc are currently priced at $47.5. At that level they are trading at 13.16% discount to the analyst consensus target price of 0.00.
Analysts covering Progyny Inc currently have a consensus Earnings Per Share (EPS) forecast of 0.338 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Progyny Inc. Over the past six months, the relative strength of its shares against the market has been 41.83%. At the current price of $47.5, shares in Progyny Inc are trading at 33.83% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Progyny Inc PE ratio based on its reported earnings over the past 12 months is 88.61. The shares are currently trading at $47.5.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Progyny Inc's management team is headed by:
Here are the top five shareholders of Progyny Inc based on the size of their shareholding:
